Skip to main content

Day: July 30, 2025

Acorn, Provider of Remote Monitoring and Control Solutions for Backup Power Generators, Hosts Q2 Earnings Call on Thur. August 7th at 11am ET

WILMINGTON, Del., July 30, 2025 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (Nasdaq: ACFN), a provider of remote monitoring and control solutions for backup power generators, gas pipelines and other industrial equipment, will report its second quarter results before the market opens on Thursday, August 7th and host an investor call at 11:00 a.m. ET. Jan Loeb, President & CEO, and Tracy Clifford, CFO & COO of OmniMetrix, will answer investor questions following their prepared remarks. All investors are encouraged to participate.Conference Call & ReplayDate/Time: Thursday, August 7th at 11:00am ETDial-in Number: 1-844-834-0644 or 1-412-317-5190 (Int’l)Online Replay/Transcript: Audio file/transcript will be posted online hereQuestions can also be submitted via Email to: acfn@catalyst-ir.com   About...

Continue reading

Cerro de Pasco Resources Reports 2025 Fiscal Year-End Financial Results and Strategic Milestones

MONTRÉAL, July 30, 2025 (GLOBE NEWSWIRE) — Cerro de Pasco Resources Inc. (CSE: CDPR) (OTCMKTS: GPPRF) (BVL: CDPR) (“CDPR” or the “Company”) announces its audited financial results for the year ended March 31, 2025. The Company significantly strengthened its financial position following the strategic realignment from the sale of non-core assets, resulting in net income of $24.6 million for the year. CDPR is now well-capitalized and strongly positioned to advance its world-class Quiulacocha Tailings Project. Fiscal 2025 Highlights (All figures in USD)Net income of $24.6 million compared to a net loss of $29.3 million for the fifteen-month period ended March 31, 2024. Earnings per share (basic and diluted) of $0.06, versus a loss of $0.09 per share in the prior period. Cash balance of $11.5 million, with positive working capital...

Continue reading

Enlight Expands Its Executive Leadership Team

Gilad Yavetz, founder of Enlight, to serve as Executive chairman of the board Adi Leviatan to be appointed CEO, bringing a proven track record of executive leadership from leading global companies; Yair Seroussi to serve as vice chairman This step, grounded in strength, and promising continuity and expansion, marks the next milestone in Enlight’s roadmap towards becoming a global leader in renewable energy TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) — Enlight Renewable Energy (“Enlight”, “the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading renewable energy platform, today announced the expansion and strengthening of its senior leadership team. Gilad Yavetz, Enlight’s Co-Founder and current CEO, will transition to a full-time role as Executive Chairman of the Board, and Adi Leviatan will be appointed as the company’s...

Continue reading

PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets

NEWPORT BEACH, Calif., July 30, 2025 (GLOBE NEWSWIRE) — PMGC Holdings Inc. (Nasdaq: ELAB) (the “Company”, “PMGC” or ”we”), a diversified public holding company, today announced that it has terminated the previously announced non-binding letter of intent, dated June 9, 2025, to acquire a profitable U.S.-based electronics manufacturing company. Following a strategic review and direction from its Board of Directors, PMGC has elected to narrow its merger and acquisition (M&A) focus toward CNC machine shops servicing the aerospace, defense, and industrial sectors. The Company believes this decision better aligns with its long-term growth strategy and capital allocation objectives, allowing it to build a highly specialized portfolio that benefits from sector-specific demand, scale efficiencies, and margin expansion. Industry Outlook The...

Continue reading

Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025

BOSTON, July 30, 2025 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that clinical data from the dose expansion cohort of the Phase 1/2 trial of solnerstotug alone and in combination with Libtayo® (cemiplimab), Regeneron’s PD-1 inhibitor, will be presented in a mini oral session at the European Society for Medical Oncology (ESMO) Congress 2025, being held October 17-21, 2025 in Berlin, Germany. Presentation Details: Title: Results from a Phase 1 expansion cohort of solnerstotug (pH-selective anti-VISTA antibody) combined with cemiplimab in patients with advanced solid tumors resistant to prior PD-(L)1 therapy Presenter: Dr. Kyriakos Papadopoulos, Co-Director of...

Continue reading

Creative Realities, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Information

LOUISVILLE, K.Y., July 30, 2025 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended June 30, 2025 before the market open on Wednesday, August 13, 2025. A conference call to review the results is scheduled for Wednesday, August 13, 2025, at 9:00 am Eastern Time, which will include prepared remarks and materials from management followed by a live Q&A. The call will be hosted by Rick Mills, Chairman and Chief Executive Officer, George Sautter, Chief Strategy Officer, and Ryan Mudd, Interim Chief Financial Officer. Prior to the call, participants should register at https://bit.ly/CREXearnings2025Q2....

Continue reading

Amerigo Announces Q2-2025 Results & Quarterly Dividend

Q2-2025 Net Income of $7.5 millionRobust EBITDA1 of $17.8 million and Free Cash Flow to Equity1 of $6.5 million16th Consecutive Quarterly Dividend of Cdn$0.03 Declared$7.6 million Returned through Dividends and Share Buybacks in Q2-2025VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce a strong financial performance for the three months ended June 30, 2025 (“Q2-2025”). Dollar amounts in this news release are in U.S. dollars unless indicated otherwise. Amerigo’s Q2-2025 financial results included net income of $7.5 million, earnings per share (“EPS”) of $0.05, EBITDA1 of $17.8 million, operating cash flow from operations before changes in non-cash working capital1 of $11.9 million and free cash flow to equity1...

Continue reading

First National Corporation Reports Record Second Quarter 2025 Earnings

STRASBURG, Va., July 30, 2025 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported earnings for the quarter ended June 30, 2025 of $5.05 million and basic and diluted earnings per common share of $0.56. Excluding acquisition-related items, adjusted earnings(1) (non-GAAP) for the second quarter of 2025 were $5.1 million and adjusted basic and diluted earnings(1) per common share were $0.57. “We are extremely pleased with our performance in the second quarter as we begin to realize the value of our recently completed acquisition of the Touchstone franchise. Earnings improved over the prior quarter and the previous year due to net interest margin expansion and our improved efficiency as a combined company. While growth was muted...

Continue reading

Verisk Signs Definitive Agreement to Acquire AccuLynx

Acquisition to expand, enhance and strengthen network capabilities across the insurance claims and restoration ecosystem Jersey City, N.J., July 30, 2025 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider to the global insurance industry, has entered into a definitive agreement to acquire AccuLynx for $2.35 billion in cash to augment its network capabilities across the insurance claims and restoration ecosystem. AccuLynx is the leading SaaS platform providing end-to-end business management workflow for residential property contractors with expertise in roofing. The acquisition is expected to be additive to Verisk’s revenue growth and adjusted EBITDA margin, and accretive to adjusted EPS by year end 2026. Strategic Rationale: Delivering Added Value to the Insurance Claims and Restoration...

Continue reading

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025

BANNOCKBURN, Ill., July 30, 2025 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial HighlightsNet revenue of $1,416.1 million, up 15.4% compared to $1,227.2 million in the second quarter of 2024 Gross profit of $269.0 million, or 19.0% of net revenue, up 7.9% compared to $249.4 million, or 20.3% of net revenue, in the second quarter of 2024 Net income of $50.5 million, compared to net income of $53.0 million, in the second quarter of 2024 and diluted earnings per share of $0.31, up 3.3% compared to diluted earnings per share of $0.30 in the second quarter of 2024 Adjusted net income of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.